VERU INC.
Biopharma firm developing drugs for cardiometabolic and inflammatory diseases.
VERU | US
Overview
Corporate Details
- ISIN(s):
- US92536C1036
- LEI:
- Country:
- United States of America
- Address:
- 2916 N. MIAMI AVENUE, 33127 MIAMI
- Website:
- https://verupharma.com/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
Veru Inc. is a late clinical-stage biopharmaceutical company dedicated to developing and commercializing novel treatments for cardiometabolic and inflammatory diseases. The company's pipeline is primarily focused on enobosarm, an oral selective androgen receptor modulator (SARM) designed to preserve muscle in patients undergoing weight loss therapy with GLP-1 drugs, thereby promoting higher-quality weight loss. Veru is also advancing sabizabulin, a novel oral anti-inflammatory agent for the treatment of atherosclerotic coronary artery disease. In addition to its cardiometabolic focus, the company has also developed therapies for oncology and viral-induced acute respiratory distress syndrome (ARDS).
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all VERU INC. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for VERU INC.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for VERU INC. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
